Plant Comparison
Field Horsetail vs Blue gum eucalyptus
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Field Horsetail and Blue gum eucalyptus: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Field Horsetail | Blue gum eucalyptus | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 2/10 | Stronger for Field Horsetail |
| Infection (general) | 5/10 | 2/10 | Stronger for Field Horsetail |
| Inflammation (general) | 5/10 | 2/10 | Stronger for Field Horsetail |
| Skin irritation | 5/10 | 2/10 | Stronger for Field Horsetail |
| Wounds | 5/10 | 2/10 | Stronger for Field Horsetail |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Field horsetail is exceptionally rich in silica, concentrated in the stem, and is a signature source of this mineral in Western herbal medicine.
Antioxidant flavonoids contributing to the plant's anti-inflammatory activity.
An enzyme that degrades vitamin B1 (thiamine); the basis of the caution against prolonged or excessive use.
Leaf essential oil dominated by 1,8-cineole (eucalyptol, typically 70%+), the principal compound responsible for the plant's antimicrobial, anti-inflammatory and expectorant/decongestant activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-rheumatic action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Field horsetail contains thiaminase, an enzyme that degrades thiamine (vitamin B1); prolonged or excessive use can cause thiamine deficiency — symptoms include neurological problems and weight loss. This risk is greatest with repeated large doses or prolonged use. The plant also contains nicotine at low levels and silica compounds. Not recommended for children or during pregnancy and breastfeeding. People with impaired kidney function should avoid use, as diuretic effects may worsen fluid and electrolyte imbalance. Caution with concurrent diuretic medications. The EMA herbal monograph recognises traditional use at appropriate short-term doses in adults only (European Medicines Agency, 2016; Sandhu et al., 2010).
Duke (2002) rates horsetail as + (moderate caution) and notes clinical evidence (score 2) for its diuretic and wound-healing (vulnerary) activities, consistent with Commission E approval. High silica content may strengthen connective tissue, hair, and nails. Dose: 6 g dried herb daily as tea or in capsules. Horsetail contains thiaminase (breaks down vitamin B1) and an unidentified neurotoxin — it should not be taken long-term or in large quantities. Not for use in patients with edema due to cardiac or renal insufficiency, and avoid in children under 12 (Duke, 2002).
Eucalyptus globulus essential oil is highly concentrated and rich in the monoterpene 1,8-cineole; it should never be applied undiluted to the skin or ingested outside of standardized pharmaceutical preparations. Improper use can cause irritation, nausea, dizziness, or neurological symptoms, and inhalation at high concentrations may provoke respiratory distress, particularly in infants, young children, or individuals with asthma or other airway sensitivities. For this reason, essential oil use is generally discouraged in children and during pregnancy unless under professional guidance. Preparations such as leaf-infused oils or external applications using whole plant material are considerably milder, but they should still be used with care and an understanding that different preparation methods carry different levels of risk.
Duke (2002) provides clinical evidence (score 2) for eucalyptus as an expectorant and topical hyperemic (rubefacient), consistent with Commission E approval. Clinical evidence also supports its use in asthma, bronchitis, and catarrh. The essential oil (primarily 1,8-cineole) is the active constituent. Therapeutic use as steam inhalation is well-established. Internal use of the essential oil at high doses is contraindicated due to toxicity; even small amounts (3.5 ml) can be fatal in children. Contraindicated for inflammatory diseases of the gastrointestinal tract or bile ducts (Duke, 2002).
External Ids
Botanical Description
Perennial, spore-bearing (non-flowering) plant with two distinct stem types arising from a deep, black, jointed rhizome. In early spring, unbranched, pale brownish fertile stems appear first, each topped with a spore-bearing cone, and die back once spores are shed; these are followed by the familiar green, hollow, jointed, ridged sterile stems bearing whorls of thin, needle-like branches at each node, giving a bottlebrush appearance.
Large, fast-growing evergreen tree with distinctive two-stage leaves: rounded, silvery-blue juvenile leaves borne in opposite pairs, giving way to narrow, sickle-shaped, aromatic, dark green mature leaves as the tree ages. Small, cream-white, fluffy flowers with numerous stamens are borne singly or in small clusters, followed by a woody, cup-shaped seed capsule ('gum nut').[12]
Habitat
Grows in damp grassland, waste ground, riverbanks, roadsides and disturbed soil on a wide range of soils; native and common across the temperate Northern Hemisphere (Europe, Asia, North America).
Native to south-eastern Australia and Tasmania; widely planted worldwide in warm-temperate and Mediterranean climates for timber, essential oil production and as an ornamental/windbreak tree.
Harvesting
The green sterile stems are cut in summer, at their most vigorous, and dried quickly in a warm, shaded, airy place; careful identification against the more toxic marsh horsetail (Equisetum palustre), which grows in similar damp ground, is essential before wild-harvesting.
Mature leaves are picked or pruned year-round and used fresh, dried, or steam-distilled for essential oil, which is the main commercial and medicinal form.
Traditional Uses
Field horsetail has a long European folk history as a diuretic remedy for urinary gravel and mild fluid retention, as an astringent, anti-inflammatory and vulnerary herb for wounds and connective-tissue support, and, owing to its very high silica content, as a traditional tonic for hair, nails and skin.[11]
Eucalyptus leaf has a long Australian Aboriginal and, after global spread, worldwide tradition as a respiratory remedy - inhaled as steam or applied as chest rubs for colds, coughs, bronchitis and catarrh - and as a topical antiseptic and rubefacient for minor wounds and muscular aches.[12]
Preparations
Dried sterile stem simmered or infused in hot water as a traditional diuretic and connective-tissue-support tea.
A few drops of essential oil, or fresh/dried leaf, added to hot water and the vapour inhaled for respiratory congestion; the classic and best-established use.
Diluted essential oil in a carrier oil or standardised ointment applied to the chest and back for coughs and colds.
Comminuted dried leaf infused in 150 ml boiling water, 1.5-3 g up to four times daily (daily dose 4.5-12 g) for oral use per the EU herbal monograph. Educational reference only, not a prescription.
Dosage
The EU herbal monograph gives a single dose of 1-4 g of the comminuted herb in 150 mL of boiling water as an infusion or decoction (5-15 minutes), 3-4 times daily, for a daily dose of 3-12 g, in adolescents, adults and elderly; traditionally used over a period of 2 to 4 weeks. For cutaneous use, 10 g in 1 L of water as a decoction for impregnated dressings and irrigation. Not recommended under 12 years. Educational reference only, not a prescription.
The EU herbal monograph on eucalyptus LEAF gives, for inhalation, 3 g of the comminuted leaf in boiling water up to 3 times daily (daily dose 3-9 g), and for oral use 1.5-3 g in 150 mL as an infusion up to 4 times daily (daily dose 4.5-12 g), in adolescents, adults and elderly. Use is CONTRAINDICATED in children under 30 months, and not recommended under 12 years. The essential oil is a separate herbal substance with its own monograph and its own posology - it is never taken internally or applied undiluted to skin on the strength of these leaf figures. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Hegedus, C., Muresan, M., Badale, A., Bombicz, M. and others (2020) 'SIRT1 Activation by Equisetum arvense L. (Horsetail) Modulates Insulin Sensitivity in Streptozotocin Induced Diabetic Rats', Molecules, 25(11), pp. 2541. doi:10.3390/molecules25112541 Preclinical
https://doi.org/10.3390/molecules25112541 - Dragos, D., Gilca, M., Gaman, L., Vlad, A., Iosif, L. et al (2017) 'Phytomedicine in Joint Disorders', Nutrients, 9(1), pp. 70. doi:10.3390/nu9010070 Traditional / reference
https://doi.org/10.3390/nu9010070 - Grundemann, C., Lengen, K., Sauer, B., Garcia-Kaufer, M. and others (2014) 'Equisetum arvense (common horsetail) modulates the function of inflammatory immunocompetent cells', BMC Complementary and Alternative Medicine, 14, pp. 283. doi:10.1186/1472-6882-14-283 Preclinical
https://doi.org/10.1186/1472-6882-14-283 - Wang, L., Zhang, L., Zheng, G. and Luo, H (2021) 'Equisetum arvense L aqueous extract: a novel chemotherapeutic supplement for treatment of human colon carcinoma', Archives of Medical Science, 19(5), pp. 1472-1478. doi:10.5114/aoms/138146 Preclinical
https://doi.org/10.5114/aoms/138146 - Jeong, S.Y., Yu, H.S., Ra, M.J., Jung, S.M. and others (2023) 'Phytochemical Investigation of Equisetum arvense and Evaluation of Their Anti-Inflammatory Potential in TNFalpha/INFgamma-Stimulated Keratinocytes', Pharmaceuticals, 16(10), pp. 1478. doi:10.3390/ph16101478 Preclinical
https://doi.org/10.3390/ph16101478 - Klncalp, S., Ekiz, F., Basar, O., Coban, S. and others (2012) 'Equisetum arvense (Field Horsetail)-induced liver injury', European Journal of Gastroenterology & Hepatology, 24(2), pp. 213-214. doi:10.1097/MEG.0b013e32834e7ff0 Preclinical
https://doi.org/10.1097/MEG.0b013e32834e7ff0 - Maeda, H., Miyamoto, K. and Sano, T (1997) 'Occurrence of dermatitis in rats fed a cholesterol diet containing field horsetail (Equisetum arvense L.)', Journal of Nutritional Science and Vitaminology, 43(5), pp. 553-563. doi:10.3177/jnsv.43.553 Preclinical
https://doi.org/10.3177/jnsv.43.553 - Saslis-Lagoudakis, C.H., Bruun-Lund, S., Iwanycki, N.E., Seberg, O. and others (2015) 'Identification of common horsetail (Equisetum arvense L.; Equisetaceae) using Thin Layer Chromatography versus DNA barcoding', Scientific Reports, 5, pp. 11942. doi:10.1038/srep11942 Preclinical
https://doi.org/10.1038/srep11942 - Mimica-Dukic, N., Simin, N., Cvejic, J., Jovin, E. and others (2008) 'Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants', Molecules, 13(7), pp. 1455-1464. doi:10.3390/molecules13071455 Preclinical
https://doi.org/10.3390/molecules13071455 - Tufarelli, V., Baghban-Kanani, P., Azimi-Youvalari, S., Hosseintabar-Ghasemabad, B. and others (2021) 'Effects of Horsetail (Equisetum arvense) and Spirulina (Spirulina platensis) Dietary Supplementation on Laying Hens Productivity and Oxidative Status', Animals, 11(2), pp. 335. doi:10.3390/ani11020335 Preclinical
https://doi.org/10.3390/ani11020335 - Carneiro, D.M., Marques, L.C., Velasques, L.O. et al (2016) 'Randomized, double-blind clinical trial to assess the acute diuretic effect of Equisetum arvense (Field Horsetail) in healthy volunteers'. doi:10.1155/2014/760683 Randomized trial
https://doi.org/10.1155/2014/760683 - European Medicines Agency (2016) 'European Union herbal monograph on Equisetum arvense L., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-equisetum-arvense-l-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-equisetum-arvense-l-herba_en.pdf - http://LatvijasDaba.lv (n.d.) 'tīruma kosa – Equisetum arvense L'. Available at: http://LatvijasDaba.lv Traditional / reference
http://LatvijasDaba.lv - Royal Botanic Gardens, Kew (n.d.) 'Equisetum arvense L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:17003330-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:17003330-1 - Sandhu, N.S., Kaur, S. and Chopra, D (2010) 'Equisetum arvense: pharmacology and phytochemistry — a review', 3(3), pp. 146--150. Traditional / reference
https://scholar.google.com/scholar?q=Equisetum%20arvense%3A%20pharmacology%20and%20phytochemistry%20%E2%80%94%20a%20review - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - NatureSpot 'Marsh Horsetail - Equisetum palustre'. Available at: https://www.naturespot.org/species/marsh-horsetail Traditional / reference
https://www.naturespot.org/species/marsh-horsetail - Muller, J. and Puttich, P.M. and Beuerle, T (2020) 'Variation of the Main Alkaloid Content in Equisetum palustre L. in the Light of Its Ontogeny', Toxins, 12(11), pp. 710. doi:10.3390/toxins12110710 Preclinical
https://doi.org/10.3390/toxins12110710 - Ibi, A. and Du, M. and Beuerle, T. and Melchert, D. and Solnier, J. and Chang, C (2022) 'A Multi-Pronged Technique for Identifying Equisetum palustre and Equisetum arvense - Combining HPTLC, HPLC-ESI-MS/MS and Optimized DNA Barcoding Techniques', Plants, 11(19), pp. 2562. doi:10.3390/plants11192562 Preclinical
https://doi.org/10.3390/plants11192562
- Čmiková, N., Galovičová, L., Schwarzová, M., Vukic, M.D. et al (2023) 'Chemical Composition and Biological Activities of Eucalyptus globulus Essential Oil', Plants (Basel), 12(5), pp. 1076. doi:10.3390/plants12051076 Preclinical
https://doi.org/10.3390/plants12051076 - Elangovan, S. and Mudgil, P (2023) 'Antibacterial Properties of Eucalyptus globulus Essential Oil against MRSA: A Systematic Review', Antibiotics (Basel), 12(3), pp. 474. doi:10.3390/antibiotics12030474 Meta-analysis / review
https://doi.org/10.3390/antibiotics12030474 - Zonfrillo, M., Andreola, F., Krasnowska, E.K., Sferrazza, G. et al (2022) 'Essential Oil from Eucalyptus globulus (Labill.) Activates Complement Receptor-Mediated Phagocytosis and Stimulates Podosome Formation in Human Monocyte-Derived Macrophages', Molecules, 27(11), pp. 3488. doi:10.3390/molecules27113488 Preclinical
https://doi.org/10.3390/molecules27113488 - Arooj, B., Asghar, S., Saleem, M., Khalid, S.H., Asif, M., Chohan, T., Khan, I.U., Zubair, H.M. and Yaseen, H.S (2023) 'Anti-inflammatory mechanisms of eucalyptol rich Eucalyptus globulus essential oil alone and in combination with flurbiprofen', Inflammopharmacology, 31(4), pp. 1849-1862. doi:10.1007/s10787-023-01237-6 Preclinical
https://doi.org/10.1007/s10787-023-01237-6 - Assaggaf, H.M., Naceiri Mrabti, H., Rajab, B.S., Attar, A.A., Hamed, M., Sheikh, R.A., Omari, N.E., Menyiy, N.E., Belmehdi, O., Mahmud, S., Alshahrani, M.M., Park, M.N., Kim, B., Zengin, G. and Bouyahya, A (2022) 'Singular and Combined Effects of Essential Oil and Honey of Eucalyptus globulus on Anti-Inflammatory, Antioxidant, Dermatoprotective, and Antimicrobial Properties: In Vitro and In Vivo Findings', Molecules, 27(16), pp. 5121. doi:10.3390/molecules27165121 Preclinical
https://doi.org/10.3390/molecules27165121 - Mulyaningsih, S., Sporer, F., Zimmermann, S., Reichling, J. and Wink, M (2010) 'Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens', Phytomedicine, 17(13), pp. 1061-1066. doi:10.1016/j.phymed.2010.06.018 Preclinical
https://doi.org/10.1016/j.phymed.2010.06.018 - Luis, A., Neiva, D., Pereira, H., Gominho, J., Domingues, F. and Duarte, A.P (2014) 'Stumps of Eucalyptus globulus as a source of antioxidant and antimicrobial polyphenols', Molecules, 19(10), pp. 16428-16446. doi:10.3390/molecules191016428 Preclinical
https://doi.org/10.3390/molecules191016428 - Merghni, A., Noumi, E., Hadded, O., Dridi, N., Panwar, H., Ceylan, O., Mastouri, M. and Snoussi, M (2018) 'Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains', Microbial Pathogenesis, 118, pp. 74-80. doi:10.1016/j.micpath.2018.03.006 Preclinical
https://doi.org/10.1016/j.micpath.2018.03.006 - Mousa, A.A., Elweza, A.E., Elbaz, H.T., Tahoun, E.A.E., Shoghy, K.M., Elsayed, I. and Hassan, E.B (2019) 'Eucalyptus Globulus protects against diclofenac sodium induced hepatorenal and testicular toxicity in male rats', Journal of Traditional and Complementary Medicine, 10(6), pp. 521-528. doi:10.1016/j.jtcme.2019.11.002 Preclinical
https://doi.org/10.1016/j.jtcme.2019.11.002 - Mota, V.S., Turrini, R.N.T. and Poveda, V.B (2015) 'Antimicrobial activity of Eucalyptus globulus oil, xylitol and papain: a pilot study', Revista da Escola de Enfermagem da USP, 49(2), pp. 216-220. doi:10.1590/S0080-623420150000200005 Preclinical
https://doi.org/10.1590/S0080-623420150000200005 - Nguyen, H.T.T., Miyamoto, A., Nguyen, H.T., Pham, H.T., Hoang, H.T., Tong, N.T.M., Truong, L.T.N. and Nguyen, H.T.T (2023) 'Antibacterial effects of essential oils from Cinnamomum cassia bark and Eucalyptus globulus leaves - the involvements of major constituents', PLoS One, 18(7), pp. e0288787. doi:10.1371/journal.pone.0288787 Preclinical
https://doi.org/10.1371/journal.pone.0288787 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - European Medicines Agency (HMPC) (2013) 'Community herbal monograph on Eucalyptus globulus Labill., folium'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-eucalyptus-globulus-labill-folium_en.pdf - Sadlon, A.E. and Lamson, D.W (2010) 'Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices', 15(1), pp. 33--47. Preclinical
https://scholar.google.com/scholar?q=Immune-modifying%20and%20antimicrobial%20effects%20of%20Eucalyptus%20oil%20and%20simple%20inhalation%20devices - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.